Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals.
Dopamine signaling is involved in a number of brain pathways, and its disruption has been suggested to be involved in the several disease states, including Parkinson's disease (PD), schizophrenia, and attention deficit hyperactivity disorder (ADHD). It has been hypothesized that altered storage, release, and reuptake of dopamine contributes to both the hypo- and hyperdopaminergic states that exist in various diseases. Here, we use our recently described mathematical model of dopamine metabolism, combined with a comprehensive Monte Carlo simulation analysis, to identify key determinants of dopamine metabolism associated with the dysregulation of dopamine homeostasis that may contribute to the pathogenesis of dopamine-based disorders. Our model reveals that the dopamine transporter (DAT), the vesicular monoamine transporter (VMAT2), and the enzyme monoamine oxidase (MAO) are the most influential components controlling the synaptic level of dopamine and the formation of toxic intracellular metabolites. The results are consistent with experimental observations and point to metabolic processes and combinations of processes that may be biochemical drivers of dopamine neuron degeneration. Since many of the identified components can be targeted therapeutically, the model may aid in the design of combined therapeutic regimens aimed at restoring proper dopamine signaling with toxic intermediates under control.
Qi
Zhen
Z
Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Miller
Gary W
GW
Voit
Eberhard O
EO
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D003198:Computer Simulation; D004298:Dopamine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000633:toxicity; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism; D005110:Extracellular Space / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000378:metabolism; D008959:Models, Neurological; D008995:Monoamine Oxidase / Q000378:metabolism; D009010:Monte Carlo Method; D009474:Neurons / Q000201:enzymology / Q000378:metabolism*; D011809:Quinones / Q000378:metabolism; D050493:Vesicular Monoamine Transport Proteins / Q000378:metabolism
D050483:Dopamine Plasma Membrane Transport Proteins; D011809:Quinones; C493452:SLC18A2 protein, human; D050493:Vesicular Monoamine Transport Proteins; D015102:3,4-Dihydroxyphenylacetic Acid; C104705:dopamine quinone; D007501:Iron; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase; D004298:Dopamine